Euripedes Constantino Miguel

Euripedes Constantino Miguel

Auto-generated profile, based on publicly available information

Euripedes Constantino Miguel

Department of Psychiatry, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2000 in The Journal of Clinical Psychiatry
Verified
Journal Article
Closed access
PDF file
EMEuripedes C. Miguel
Euripedes C. Miguel
MRMaria Conceição Do Rosário-Campos
Maria Conceição Do Rosário-Campos
HPHelena da Silva Prado
Helena da Silva Prado
RVRaquel Do Valle
Raquel Do Valle
SRScott L. Rauch
Scott L. Rauch
JLJames F. Leckman
James F. Leckman
From The Journal of Clinical Psychiatry:

7 January 2021 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
ESElizabeth Shephard
Elizabeth Shephard
ESEmily R. Stern
Emily R. Stern
OHOdile A. van Den Heuvel
Odile A. van Den Heuvel
DCDaniel L. C. Costa
Daniel L. C. Costa
MBMarcelo C. Batistuzzo
Marcelo C. Batistuzzo
EMEuripedes C. Miguel
Euripedes C. Miguel

21 December 2004 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
EME C Miguel
E C Miguel
JLJ F Leckman
J F Leckman
SRS Rauch
S Rauch
MRM C Do Rosario-Campos
M C Do Rosario-Campos
AHA G Hounie
A G Hounie
DPD L Pauls
D L Pauls
Obsessive-compulsive disorder (OCD) clinical presentation is remarkably diverse, and can vary both within and across patients over time. This variability in the phenotypic expression has led to the hypothesis that OCD is a heterogeneous disorder and that this heterogeneity obscures the findings of clinical, natural history and treatment response studies and complicates the search for vulnerability genes. A complete understanding of what comprises OCD and the underlying etiological mechanisms will require a dramatic change in how the disorder is conceptualized. In this review, several different approaches that may represent the first steps in this reconceptualization are discussed. These approaches include (1) narrowing the phenotype to identify categorically defined more homogeneous and mutually exclusive subtypes of OCD, (2) considering OC symptom dimensions as quantitative components of the more complex OCD phenotype and (3) broadening the phenotype to include other etiologically related conditions. A combined dimensional approach within distinctive subgroups is proposed as probably the most effective in helping to identify the heritable components of OCD. By identifying heritable components of OCD, it should be possible to find genes for these separate components. The review continues with the illustration of the possible role of some epigenetic risk and protective factors in the OCD presentation and the relevance of examining associated traits and/or endophenotypes to enhance our ability to understand the genetic basis of OCD. To conclude, we discuss the variability in treatment outcome and the significance of the development of specific pharmacological and/or behavioral based therapies tailored to each of these phenotypes.

28 July 2022 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
BBBorwin Bandelow
Borwin Bandelow
CAChrister Allgulander
Christer Allgulander
DBDavid S. Baldwin
David S. Baldwin
DCDaniel Lucas da Conceição Costa
Daniel Lucas da Conceição Costa
DDDamiaan Denys
Damiaan Denys
JZJoseph Zohar
Joseph Zohar
This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Po...

9 May 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
EMEuripedes C. Miguel
Euripedes C. Miguel
ALAntonio C. Lopes
Antonio C. Lopes
NMNicole C. R. McLaughlin
Nicole C. R. McLaughlin
GNGeorg Norén
Georg Norén
AGAndré F. Gentil
André F. Gentil
SSSameer A. Sheth
Sameer A. Sheth
For more than half a century, stereotactic neurosurgical procedures have been available to treat patients with severe, debilitating symptoms of obsessive-compulsive disorder (OCD) that have proven refractory to extensive, appropriate pharmacological, and psychological treatment. Although reliable predictors of outcome remain elusive, the establishment of narrower selection criteria for neurosurgical candidacy, together with a better understanding of the functional neuroanatomy implicated in OCD, has resulted in improved clinical efficacy for an array of ablative and non-ablative intervention techniques targeting the cingulum, internal capsule, and other limbic regions. It was against this backdrop that gamma knife capsulotomy (GKC) for OCD was developed. In this paper, we review the history of this stereotactic radiosurgical procedure, from its inception to recent advances. We perform a systematic review of the existing literature and also provide a narrative account of the evolution of the procedure, detailing how the procedure has changed over time, and has been shaped by forces of evidence and innovation. As the procedure has evolved and adverse events have decreased considerably, favorable response rates have remained attainable for approximately one-half to two-thirds of individuals treated at experienced centers. A reduction in obsessive-compulsive symptom severity may result not only from direct modulation of OCD neural pathways but also from enhanced efficacy of pharmacological and psychological therapies working in a synergistic fashion with GKC. Possible complications include frontal lobe edema and even the rare formation of delayed radionecrotic cysts. These adverse events have become much less common with new radiation dose and targeting strategies. Detailed neuropsychological assessments from recent studies suggest that cognitive function is not impaired, and in some domains may even improve following treatment. We conclude this review with discussions covering topics essential for further progress of this therapy, including suggestions for future trial design given the unique features of GKC therapy, considerations for optimizing stereotactic targeting and dose planning using biophysical models, and the use of advanced imaging techniques to understand circuitry and predict response. GKC, and in particular its modern variant, gamma ventral capsulotomy, continues to be a reliable treatment option for selected cases of otherwise highly refractory OCD.

13 May 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NSNora I. Strom
Nora I. Strom
ZGZachary F. Gerring
Zachary F. Gerring
MGMarco Galimberti
Marco Galimberti
DYDongmei Yu
Dongmei Yu
MHMatthew W. Halvorsen
Matthew W. Halvorsen
CGChris German
Chris German
Obsessive–compulsive disorder (OCD) affects ~1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3 and CTNND1 and multiple genes in the major histocompatibility complex (MHC) region. We estimated that ~11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and the cortex, along with D1 and D2 type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa and Tourette syndrome and was negatively associated with inflammatory bowel diseases, educational attainment and body mass index.